NCT01600950View on ClinicalTrials.gov

A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With Type 1 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

LY2963016

Single 0.3 U/kg dose administered subcutaneously

DRUG

Lantus

Single 0.3 U/kg dose administered subcutaneously

Trial Locations (1)

41460

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Neuss

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01600950 - A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter